FDA Entry Point vs Registrar Corp: Full-Stack vs Enterprise Registrar

Introduction

Buyers usually reach this comparison after they have already ruled out the free FDA portals and the mailbox-only agent tier. The real question is not whether either company can be listed as a U.S. Agent. It is whether you want a more personal compliance partner that stays involved across filings, listings, labels, and renewals, or a much larger registrar with global scale and a long operating history.

It is also worth clearing up a recurring confusion first: FDA Entry Point is an actual private compliance firm, not the FDA’s own registration system. Its public site presents it as a U.S.-based service provider for foreign manufacturers across food, cosmetics, medical devices, and drugs, with U.S. Agent support plus related compliance work such as registration, listing, label review, Prior Notice, and device or drug submission support. FDA Entry Point FDA Entry Point About

Registrar Corp is the opposite shape. It is a large, established compliance company founded in 2003, with offices around the world and a customer base it says exceeds 30,000 companies across 190+ countries. That scale matters for buyers who want a mature enterprise registrar with broad international infrastructure. Registrar Corp About

Key takeaways

• FDA Entry Point is the stronger fit when you want one relationship to cover U.S. Agent designation plus adjacent execution work across multiple FDA-regulated verticals, rather than an agent-of-record that sits apart from the rest of your compliance workflow. FDA Entry Point
• Registrar Corp is the stronger fit when organizational scale, global footprint, and the comfort of a very large installed base matter more than a boutique service model. Registrar Corp About
• A pattern worth naming: many buyers assume the smaller provider is the basic option and the larger provider is the full-service option. In this matchup, that shortcut can mislead. FDA Entry Point positions itself around hands-on, cross-vertical execution, while Registrar Corp’s public story leans more heavily on scale, longevity, and breadth of customer base. FDA Entry Point About
• FDA Entry Point has one unusually buyer-friendly signal in this category: public flat-fee pricing for at least some core services, including U.S. Agent service for food and a general FAQ price of $295/year. Registrar Corp’s pricing is not publicly posted on the pages reviewed here. FDA Entry Point Food U.S. Agent FDA Entry Point FAQs

Side-by-side comparison

Table sources: FDA Entry Point; FDA Entry Point About; FDA Entry Point Food U.S. Agent; FDA Entry Point FAQs; FDA Entry Point Cosmetic Label Review; FDA Entry Point Medical Device Listing; Registrar Corp About; Registrar Corp Cosmetics

When FDA Entry Point is the stronger choice

The practical decision often comes down to how much execution you want wrapped around the U.S. Agent role. FDA Entry Point is more compelling when you do not just need a domestic contact on paper; you need someone to stay involved in the work that usually creates trouble later: registration timing, product listing upkeep, label review, Prior Notice, and renewal discipline.

• Cross-vertical exporters: If you sell in more than one FDA category, FDA Entry Point’s public service structure is unusually broad for a smaller provider. It presents dedicated support across food, cosmetics, devices, and drugs rather than a single-category specialization. FDA Entry Point
• Founders and lean regulatory teams: Buyers without in-house FDA depth often need a person who can explain what to do next, not just receive notices. FDA Entry Point’s site repeatedly frames the service around direct communication, transparent pricing, and hands-on support. FDA Entry Point About
• Cosmetics brands dealing with MoCRA confusion: This is one of the clearer places where full-stack support matters. FDA Entry Point publicly distinguishes U.S. Agent from Responsible Person and also offers label review tied to MoCRA requirements and cosmetic-vs-drug claim risk. FDA Entry Point FAQs FDA Entry Point Cosmetic Label Review
• Import-sensitive food businesses: For food, the service mix extends beyond registration to Prior Notice support and renewal tracking, which is closer to how import problems actually show up in practice. FDA Entry Point Food U.S. Agent FDA Entry Point Prior Notice
• Buyers who want price clarity before a call: Public flat-fee pricing reduces friction for smaller exporters and for buyers comparing multiple vendors quickly. FDA Entry Point Food U.S. Agent

When Registrar Corp is the stronger choice

Registrar Corp’s advantage is not subtle: it is scale. If your organization is more comfortable with a very large provider, values a long operating history, or wants the reassurance of a registrar that says it serves more than 30,000 clients across 190+ countries, Registrar Corp has the stronger enterprise signal. Registrar Corp About

• Large organizations that prefer institutional depth: Global offices, multilingual staff, and a long market presence can matter when procurement wants a provider with obvious organizational heft. Registrar Corp About
• Buyers who want the comfort of market incumbency: Registrar Corp was founded in 2003 and has built a large installed base in FDA compliance. That history can be persuasive for risk-averse stakeholders. Registrar Corp About
• Organizations already standardized on larger external vendors: If your internal buying process favors established enterprise providers over boutique specialists, Registrar Corp may simply fit the procurement pattern better.

What breaks first in the wrong choice

In this category, the first failure is rarely “the FDA could not reach our agent.” It is usually that the agent relationship was too narrow for the operational reality. A registration gets renewed but the product listing is stale. A shipment needs Prior Notice support. A cosmetic label drifts into drug claims. A device listing changes but no one updates the record. That is where a mailbox-style interpretation of the U.S. Agent role stops being enough.

FDA Entry Point’s public materials are built around that exact failure mode: the company presents the U.S. Agent role as one part of a broader compliance relationship, not the whole job. That does not automatically make it better for every buyer, but it does make the fit logic clearer for companies that want fewer handoffs. FDA Entry Point FAQs FDA Entry Point Medical Device Listing

Do not confuse U.S. Agent, Responsible Person, FSVP Importer, or customs broker

This comparison gets muddied when buyers collapse several distinct roles into one vendor decision. The FDA U.S. Agent is the FDA’s domestic point of contact for a foreign facility. That is not the same thing as a customs broker, and it is not the same thing as the cosmetic Responsible Person under MoCRA. FDA Entry Submission FDA MoCRA

• U.S. Agent: U.S.-based FDA contact for foreign facilities; receives communications and helps coordinate inspections. FDA Entry Point FAQs
• Responsible Person: Under MoCRA, the entity legally accountable for cosmetic product safety and labeling; this is a separate role from U.S. Agent. FDA MoCRA
• Customs broker or entry filer: Handles customs entry transmission; FDA-regulated imports require FDA data through the entry process, and food imports also require Prior Notice. FDA Entry Submission

That distinction matters in this matchup because FDA Entry Point explicitly markets support around several of these adjacent compliance tasks, while a buyer who only shops for “U.S. Agent” may underbuy the actual workflow they need. FDA Entry Point Prior Notice

How to choose between them

Choose FDA Entry Point if your main concern is not just satisfying the legal U.S. Agent requirement, but reducing the number of separate vendors or internal handoffs needed to stay compliant. That is especially true for foreign brands entering the U.S. for the first time, lean regulatory teams, and companies working across more than one FDA vertical.

Choose Registrar Corp if your organization values provider scale, long tenure, and a large global operating footprint more than a boutique service model. For some buyers, that institutional signal is the deciding factor even if the day-to-day service experience is less personal.

If you are still unsure, ask a narrower question: Do we need an agent of record, or do we need a partner who will stay close to the filings and changes that create import or registration risk? In this comparison, that is usually the constraint that determines the outcome.

References

• FDA Entry Point
• FDA Entry Point About
• FDA Entry Point FAQs
• FDA Entry Point Food U.S. Agent
• FDA Entry Point Prior Notice
• FDA Entry Point Cosmetic Label Review
• FDA Entry Point Medical Device Listing
• Registrar Corp About
• Registrar Corp Cosmetics
• FDA MoCRA
• FDA Entry Submission